NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE210114 Query DataSets for GSE210114
Status Public on Nov 23, 2022
Title BET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 36378541
Submission date Jul 29, 2022
Last update date Nov 26, 2022
Contact name Haobin Chen
E-mail(s) [email protected]
Phone (845) 300-2498
Organization name National Institutes of Health
Department Thoracic Surgery Branch
Street address 10 Center Drive, Room 3-5888
City Bethesda
State/province MD
ZIP/Postal code 20892
Country USA
 
Platforms (2)
GPL20301 Illumina HiSeq 4000 (Homo sapiens)
GPL21290 Illumina HiSeq 3000 (Homo sapiens)
Samples (71)
GSM6421390 H446 cells, Non-targeting gRNA, clone 3, DMSO, biol rep 1
GSM6421391 H446 cells, Non-targeting gRNA, clone 3, DMSO, biol rep 2
GSM6421392 H446 cells, Non-targeting gRNA, clone 3, DMSO, biol rep 3
This SuperSeries is composed of the following SubSeries:
GSE210101 BET inhibitors target the SCLC-N subtype of small-cell lung cancer by blocking NEUROD1 transactivation
GSE210104 BET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation
GSE210110 BET Inhibitors Target the SCLC-N subtype of Small Cell Lung Cancer by Blocking NEUROD1 Transactivation
Relations
BioProject PRJNA863665

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE210114_RAW.tar 11.9 Mb (http)(custom) TAR (of BROADPEAK, NARROWPEAK)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap